DAY 2 HALL A&B INDUSTRY TALK HOSTED BY AMGEN
AGENDA
INDUSTRY TALK HOSTED BY AMGEN

Redefining LDL-C Management in ACS Patients: Time to Act
Dr. Peter James Lin (Canada)